Recent Updates
Recently added Catalysts
ORGO Neutral Sentiment

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

Thursday, June 6, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Organogenesis Holdings Inc. will participate in the Truist Securities MedTech Conference on June 18, 2024, at the InterContinental Boston. The company specializes in regenerative medicine, particularly for advanced wound care and surgical markets. During the conference, management will engage in one-on-one meetings without delivering a formal presentation. This involvement reflects the company's commitment to industry visibility and stakeholder engagement.
Price reaction · baseline $2.65 (2024-06-05 close) · hit after-hours · clean, no other ORGO news in the window
day 0 close · peak
+1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a notable conference showcases credibility.
  • No negative events reported, indicating stable operations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~4 mo
High dilution risk
Lead asset
Amniotic Allograft
Phase 3 · Knee Osteoarthritis

Full Press Release Details

CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the Truist Securities MedTech Conference, which is being held at the InterContinental Boston in Boston, MA on Tuesday, June 18th. Management will participate in 1x1 meetings. There will be no formal presentation.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.

Frequently Asked Questions

What event will Organogenesis participate in on June 18, 2024?

Organogenesis will participate in the Truist Securities MedTech Conference.

Where is the Truist Securities MedTech Conference held?

The conference will be held at the InterContinental Boston, MA.

Will Organogenesis give a presentation at the conference?

No, there will be no formal presentation by Organogenesis at the event.

What markets does Organogenesis focus on?

Organogenesis focuses on advanced wound care and surgical and sports medicine.

How can I learn more about Organogenesis products?

More information about Organogenesis can be found on their website.

ShareAdd on Google
Tags: ORGO Viatris Investor Conferences Healthcare Organogenesis MedTech Conference regenerative medicine advanced wound care
Last updated: Jun 6, 2024

Biotech snapshot

Cash runway
$47M liquidity · $11M/mo burn
~4 mo
High dilution risk
Lead asset
Amniotic AllograftPhase 3
Knee Osteoarthritis →